Peptic Ulcer Disease
📧 Sign up to get email alerts when something new happens for Peptic Ulcer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-05-30FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for the combination drug Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochlor…
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: Prevention of Recurrent Ulcer Bleeding in High-risk Aspirin Users Who Are Not Infected With Helicobacter Pylori
This trial update reports a completed study evaluating prevention of recurrent ulcer bleeding in high-risk aspirin users who are not infecte…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Doppler Ultrasound Probe for Blood Flow Detection in Severe Upper Gastrointestinal Hemorrhage [NA]
Clinical trial completed evaluating a Doppler ultrasound probe for detecting blood flow in severe upper gastrointestinal hemorrhage.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers [Phase 3]
Phase 3 trial evaluating the optimal dose of omeprazole after endoscopic treatment of bleeding peptic ulcers has completed.
-
FDA approval · 2017-02-07FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC (ANDA 077824).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers [Phase 1]
This Phase 1 study evaluated the safety and potential drug-drug interaction between lafutidine and irsogladine maleate in healthy adult volu…
-
FDA approval · 2017-01-25FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the fixed-dose combination of bismuth subcitrate potassium, metronidazole, and tetracycline hydr…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy [Phase 4]
This Phase 4 trial compares berberine quadruple therapy to clarithromycin quadruple therapy for eradicating Helicobacter pylori in patients …
-
FDA label_change · 2017-01-13FDA Approved: LIBRAX — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for Librax (chlordiazepoxide hydrochloride and clidinium bromide) submitted by Bausch Health US, LLC…
-
FDA label_change · 2016-12-19FDA Approved: CYTOTEC — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Cytotec (misoprostol) from Pfizer Laboratories Div Pfizer Inc, resulting in a labeling update.
-
CLINICAL_TRIALS research · 2016-11-10Clinical Trial Update: Helicobacter Pylori Antibiotic Susceptibility Testing of Korea
This clinical trial update describes a Korean study investigating antibiotic susceptibility testing for Helicobacter pylori. The conditions …
-
FDA approval · 2016-10-07FDA Approved: LANSOPRAZOLE, AMOXICILLIN, CLARITHROMYCIN — Original Application (Rising Pharma Holdings, Inc.)
FDA approved a new generic triple-therapy combination of lansoprazole, amoxicillin, and clarithromycin (Original Application) from Rising Ph…
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department
A completed clinical trial evaluating Helicobacter pylori testing in patients with non-specific upper abdominal pain in the emergency depart…
-
FDA approval · 2016-08-10FDA Approved: ESOMEPRAZOLE SODIUM — Original Application (Eugia US LLC)
FDA approved Eugia US LLC's original application for esomeprazole sodium, a generic proton pump inhibitor, confirming a generic version of t…
-
FDA approval · 2016-08-01FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for PEPCID AC MAXIMUM STRENGTH (famotidine) by Kenvue Brands LLC, updating the product labeling as p…
-
FDA approval · 2016-06-06FDA Approved: CARAFATE — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for CARAFATE (sucralfate) submitted by Allergan, Inc.
-
FDA approval · 2016-05-09FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for diclofenac sodium and misoprostol from Mylan Pharmaceuticals Inc., marking an approved chang…
-
FDA approval · 2016-04-22FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Esomeprazole Magnesium (generic esomeprazole magnesium) submitted by NorthStar Rx LLC.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Epidemiology of H. Pylori Transmission
This clinical trial study examined the epidemiology of Helicobacter pylori transmission and is now completed.
-
FDA approval · 2016-04-04FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for Pantoprazole Sodium from NorthStar Rx LLC under ANDA202038.
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Serum Zinc, Peptic Ulcer Disease and H. Pylori Infection
A completed clinical trial update examining the relationship between serum zinc levels and peptic ulcer disease in the context of Helicobact…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer [Phase 3]
A Phase 3 trial evaluated high-dose esomeprazole sodium for preventing rebleeding after successful endoscopic therapy of a bleeding peptic u…
-
FDA approval · 2016-02-26FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the fixed-dose combination of bismuth subcitrate potassium, metronidazole, and tetracycline hydr…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot [Phase 4]
A Phase 4 clinical trial evaluated different doses of intravenous omeprazole to treat bleeding peptic ulcers with adherent clots.
-
FDA approval · 2016-02-03FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) submitted by Covis Pharma US, Inc. The approval pertains to a mo…